Does Statin Initiation Undermine Dietary Behavior?

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
Weill Medical College of Cornell University
ClinicalTrials.gov Identifier:
NCT00224159
First received: September 20, 2005
Last updated: February 18, 2011
Last verified: February 2011
  Purpose

The purpose of this research is to improve our understanding of the effects that taking cholesterol reducing pills have on dietary behavior as well as other health related behaviors


Condition Intervention
All English Speaking Adults From the Manhattan VA Clinic Who Have Recently Received Their First Prescription for a Statin
Behavioral: Drug and Dietary behavior

Study Type: Observational
Official Title: Does Statin Initiation Undermine Dietary Behavior?

Resource links provided by NLM:


Further study details as provided by Weill Medical College of Cornell University:

Primary Outcome Measures:
  • How drug or dietary therapy may play a role in dietary behavior.

Estimated Enrollment: 100
Study Start Date: February 2005
Estimated Study Completion Date: June 2006
Detailed Description:

This study explores the impact of initiating statin therapy on subsequent dietary as well as other lifestyle beliefs, attitudes and behaviors.

Specific aims:

  1. To test whether the initiation of statin therapy increases dietary saturated fat intake among statin naive patients.
  2. To determine what role attitudes, beliefs, expectations, motivation, intention and self-efficacy regarding drug or diet therapy may play in observed changes in dietary behavior after starting statin therapy.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All English-speaking adults who have recently (within 1 week)received their first prescription for a statin will be eligible.

Criteria

Inclusion Criteria:

All English-speaking adults who have recently (within 1 week)received their first prescription for a statin will be eligible.

Exclusion Criteria:

Will include a history of any of the following:

  1. Prior CVD (myocardial infarction, angina, angioplasty, stroke, CABG. or arterial bypass surgery)
  2. Diabetes patients
  3. Psychiatric patients
  4. AIDS patients
  5. Substance abuse patients
  6. Prior cholesterol lowering medication use
  7. Inability to complete the interviews
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00224159

Locations
United States, New York
The New York Presbyterian Hospital-Weill Medical Center
New York, New York, United States, 10021
Sponsors and Collaborators
Weill Medical College of Cornell University
Investigators
Principal Investigator: Sundar Natarajan, MD, MSc Weill Medical College of Cornell University
Principal Investigator: Devin Mann, MD Weill Medical College of Cornell University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00224159     History of Changes
Other Study ID Numbers: 00710
Study First Received: September 20, 2005
Last Updated: February 18, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Weill Medical College of Cornell University:
Statin therapy
Dietary behavior
Attitudes and beliefs
Self efficacy

ClinicalTrials.gov processed this record on August 19, 2014